Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms (2012J8)
Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (2011J1)
Diabetes (2010Z6)
Type 2 Diabetes and Insulin Resistance (2009J3)

Web Desc
Diabetes Mellitus, Insulin Action and Resistance Organizer(s): Mary-Elizabeth Patti and David E. Moller Date: January 22 - 27, 2008 Location: Beaver Run Resort, Breckenridge, CO, USA Part of the Translational Medicine Series, Sponsored by Pfizer Global Research & Development Summary of Meeting: The incidence of type 2 diabetes is increasing worldwide at an alarming rate – mandating intensive efforts to improve our understanding of diabetes pathophysiology, improve options for therapy, and most importantly, to initiate strategies for disease prevention in high-risk groups. This meeting will focus on recent advances in our understanding of the molecular pathogenesis of insulin resistance, diabetes, and related syndromes, with particular emphasis on (1) multi-system nature of diabetes pathophysiology, (2) genetic basis of insulin resistance and diabetes risk, (3) potential links between epigenetic modulation of gene expression and diabetes risk related to “environmental” mechanisms, (4) pathways linking obesity, inflammation, and diabetes risk, and (5) new molecular mechanisms of insulin resistance. Moreover, the meeting will highlight novel pharmacologic targets for diabetes therapy. A key goal of the meeting will also be to facilitate collaborative interactions between basic scientists and translational clinical scientists focused on prevention and treatment of insulin resistance and diabetes. Scholarship Deadline: September 24 2007 Discounted Abstract Deadline: September 24 2007 Abstract Deadline: October 25 2007 Discounted Registration Deadline: November 26 2007 We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: Educational grant from Lilly USA, LLC We gratefully acknowledge the generous grant for this conference provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant No. 5R13DK076500-02 We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Diabetes Mellitus, Insulin Action and Resistance

Organizer(s): Mary-Elizabeth Patti and David E. Moller

Date: January 22 - 27, 2008
Location: Beaver Run Resort, Breckenridge, CO, USA

Part of the Translational Medicine Series, Sponsored by Pfizer Global Research & Development

Summary of Meeting:

The incidence of type 2 diabetes is increasing worldwide at an alarming rate – mandating intensive efforts to improve our understanding of diabetes pathophysiology, improve options for therapy, and most importantly, to initiate strategies for disease prevention in high-risk groups. This meeting will focus on recent advances in our understanding of the molecular pathogenesis of insulin resistance, diabetes, and related syndromes, with particular emphasis on (1) multi-system nature of diabetes pathophysiology, (2) genetic basis of insulin resistance and diabetes risk, (3) potential links between epigenetic modulation of gene expression and diabetes risk related to “environmental” mechanisms, (4) pathways linking obesity, inflammation, and diabetes risk, and (5) new molecular mechanisms of insulin resistance. Moreover, the meeting will highlight novel pharmacologic targets for diabetes therapy. A key goal of the meeting will also be to facilitate collaborative interactions between basic scientists and translational clinical scientists focused on prevention and treatment of insulin resistance and diabetes.

Scholarship Deadline: September 24 2007

Discounted Abstract Deadline: September 24 2007

Abstract Deadline: October 25 2007

Discounted Registration Deadline: November 26 2007

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Educational grant from Lilly USA, LLC

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK076500-02

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Tuesday, January 22 \| 3:00PM - 7:30PM Registration Room: Foyer
Tuesday, January 22 \| 6:30PM - 7:30PM Refreshments Room: Foyer
Tuesday, January 22 \| 7:30PM - 9:30PM Keynote Session Room: Colorado Ballroom Speaker 1 of 4 * Mary-Elizabeth Patti, Joslin Diabetes Center, USA and
Tuesday, January 22 \| 7:30PM - 9:30PM Keynote Session Room: Colorado Ballroom Speaker 2 of 4 * David E. Moller, Eli Lilly and Company, USA Introductory Remarks
Tuesday, January 22 \| 7:30PM - 9:30PM Keynote Session Room: Colorado Ballroom Speaker 3 of 4 C. Ronald Kahn, Joslin Diabetes Center and Harvard Medical School, USA Insulin Resistance, Obesity and Type 2 Diabetes: Which is the Chicken and Which is the Egg?
Tuesday, January 22 \| 7:30PM - 9:30PM Keynote Session Room: Colorado Ballroom Speaker 4 of 4 Leif C. Groop, Lund University, Sweden Searching for the Genetic Causes of Type 2 Diabetes
Wednesday, January 23 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 1 of 7 * Mary-Elizabeth Patti, Joslin Diabetes Center, USA
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 2 of 7 Ele Ferrannini, University of Pisa, Italy Overview: Relative Role of Insulin Resistance vs. Beta Cell Dysfunction in Diabetes Pathogenesis
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 3 of 7 Hannele Yki-Järvinen, University of Helsinki, Finland Role of Fatty Liver in the Pathogenesis of Metabolic Syndrome and Type 2 Diabetes
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 4 of 7 Gerald I. Shulman, Yale University School of Medicine, USA Cellular Mechanisms of Insulin Resistance and the Role of Skeletal Muscle Insulin Resistance in the Pathogenesis of the Metabolic Syndrome
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 5 of 7 Gökhan S. Hotamisligil, Harvard School of Public Health, USA Inflammation and ER Stress in Metabolic Disease
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 6 of 7 Michael Ristow, Swiss Federal Institute of Technology Zurich - ETH, Switzerland Short Talk: Impaired Oxidative Phosphorylation Induces Oxidative Stress, Decreases Life Span and Promotes Type 2 Diabetes and Obesity
Wednesday, January 23 \| 8:00AM - 11:15AM Insulin Resistance and Diabetes Pathogenesis Room: Colorado Ballroom Speaker 7 of 7 J. Andrew Pospisilik, Van Andel Institute, USA Short Talk: Targeted Deletion of AIF Reduces OxPhos and Prevents Diabetes and Obesity
Wednesday, January 23 \| 9:20AM - 9:40AM Coffee Break Room: Foyer
Wednesday, January 23 \| 11:15AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Wednesday, January 23 \| 12:00PM - 1:30PM Meet the Professor Lunch: NIH Grant Application Process and Endo-Related Study Sessions Room: Colorado Ballroom Box Lunches available for purchase. Advance sign-up will be required. Speaker 1 of 2 * Mary-Elizabeth Patti, Joslin Diabetes Center, USA Introduction
Wednesday, January 23 \| 12:00PM - 1:30PM Meet the Professor Lunch: NIH Grant Application Process and Endo-Related Study Sessions Room: Colorado Ballroom Box Lunches available for purchase. Advance sign-up will be required. Speaker 2 of 2 * Philip F. Smith, NIDDK, National Institutes of Health, USA
Wednesday, January 23 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Wednesday, January 23 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Wednesday, January 23 \| 5:00PM - 7:00PM Genetics and Syndromes Related to Type 2 Diabetes Room: Colorado Ballroom Speaker 1 of 5 * Leif C. Groop, Lund University, Sweden
Wednesday, January 23 \| 5:00PM - 7:00PM Genetics and Syndromes Related to Type 2 Diabetes Room: Colorado Ballroom Speaker 2 of 5 Philippe Froguel, Imperial College of London, UK Human Polygenic Severe Obesity Genes, What's New? What's Interesting?
Wednesday, January 23 \| 5:00PM - 7:00PM Genetics and Syndromes Related to Type 2 Diabetes Room: Colorado Ballroom Speaker 3 of 5 Leslie J. Baier, National Institutes of Health, USA The Search for Type 2 Diabetes and Obesity Susceptibility Genes in Pima Indians
Wednesday, January 23 \| 5:00PM - 7:00PM Genetics and Syndromes Related to Type 2 Diabetes Room: Colorado Ballroom Speaker 4 of 5 Andrea Dunaif, Icahn School of Medicine at Mount Sinai, USA PCOS and Type 2 Diabetes – Insights from Genetic Studies
Wednesday, January 23 \| 5:00PM - 7:00PM Genetics and Syndromes Related to Type 2 Diabetes Room: Colorado Ballroom Speaker 5 of 5 Jeremy B.M. Jowett, Baker IDI Heart and Diabetes Institute, Australia Short Talk: A Systems Biology Approach to Determining the Biological Consequences of Genetic Variation in Humans: The PPAR gamma Pro12Ala Variant
Wednesday, January 23 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom
Wednesday, January 23 \| 7:30PM - 10:00PM Poster Session 1 Room: Breckenridge Ballroom
Thursday, January 24 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 1 of 7 * Michael P. Czech, University of Massachusetts Medical School, USA
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 2 of 7 Isaac S. Kohane, Harvard Medical School, USA Getting Better and More Numbers for Discovery Research in the Genomic Era
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 3 of 7 Lily Q. Dong, University of Texas Health Science Center, USA Short Talk: “Ying-Yang” Regulation of Adiponectin Signaling by APPL Isoforms
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 4 of 7 Rosalind A. Coleman, University of North Carolina at Chapel Hill, USA Lipogenic Pathways: Links to Diabetes Risk
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 5 of 7 Steven E. Shoelson, Harvard Medical School, Joslin Diabetes Center, USA Potent Roles of the Immune System in Obesity Induced T2DM and CVB
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 6 of 7 Mitchell A. Lazar, Perelman School of Medicine, University of Pennsylvania, USA Transcriptional Networks Leading From Obesity to Insulin Resistance
Thursday, January 24 \| 8:00AM - 11:15AM Adipose and Inflammatory Links to Insulin Resistance Room: Colorado Ballroom Speaker 7 of 7 David A. Bernlohr, University of Minnesota, USA Short Talk: Role of Adipose Protein Carbonylation in Insulin Resistance; The HNE Pathway
Thursday, January 24 \| 9:20AM - 9:40AM Coffee Break Room: Foyer
Thursday, January 24 \| 11:15AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Thursday, January 24 \| 12:00PM - 1:30PM Meet the Professor Lunch: Clinical DM for PhDs Room: Colorado Ballroom Speaker 1 of 2 * Mary-Elizabeth Patti, Joslin Diabetes Center, USA Introduction
Thursday, January 24 \| 12:00PM - 1:30PM Meet the Professor Lunch: Clinical DM for PhDs Room: Colorado Ballroom Speaker 2 of 2 * Martin J. Abrahamson, Harvard Medical School, USA
Thursday, January 24 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Thursday, January 24 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 1 of 6 * Mitchell A. Lazar, Perelman School of Medicine, University of Pennsylvania, USA
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 2 of 6 Miguel Constância, University of Cambridge, UK Epigenetics: Basic Mechanisms and Potential Links to Developmental Origins of Adult Disease
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 3 of 6 Kevin L. Grove, Novo Nordisk, USA Short Talk: Maternal High Fat Diet Causes Fetal Lipotoxicity
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 4 of 6 Mary-Elizabeth Patti, Joslin Diabetes Center, USA Genetic and Environmental Pathways to Human Diabetes Risk
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 5 of 6 Don Ayer, University of Utah, USA Short Talk: Glucose Sensing and Regulation of Glucose-Dependent Transcription
Thursday, January 24 \| 5:00PM - 7:15PM Epigenetic and Metabolic Determinants of Insulin Resistance and Diabetes Risk Room: Colorado Ballroom Speaker 6 of 6 Assam El-Osta, Monash University, Australia Short Talk: Transient Hyperglycemia Induces Persistent Transcriptional Activity; Insights into Epigenetic Change and Glycemic Memory
Thursday, January 24 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Breckenridge Ballroom
Thursday, January 24 \| 7:30PM - 10:00PM Poster Session 2 Room: Breckenridge Ballroom
Friday, January 25 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 1 of 7 * David E. Moller, Eli Lilly and Company, USA
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 2 of 7 Alan D. Attie, University of Wisconsin-Madison, USA Multidimensional Approaches to DM Gene Discovery
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 3 of 7 Michael P. Czech, University of Massachusetts Medical School, USA Systems Biology Approaches to Metabolic Disease
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 4 of 7 Alexei Kharitonenkov, Novo Nordisk, USA Metabolic Actions of FGF-21
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 5 of 7 D. Grahame Hardie, University of Dundee, UK AMP-Activated Protein Kinase as a Drug Target in Type 2 Diabetes and Metabolic Syndrome
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 6 of 7 Carsten Schmitz-Peiffer, Garvan Institute of Medical Research, Australia Short Talk: Inhibition of PKCepsilon is a Potential Therapy for Type 2 Diabetes by Reconstituting Glucose-Stimulated Insulin Secretion and Reducing Insulin Clearance
Friday, January 25 \| 8:00AM - 11:15AM Searching for New Therapeutic Targets Room: Colorado Ballroom Speaker 7 of 7 Joe S. Grimsby, AstraZeneca, USA Short Talk: Antidiabetic Effects of Glucokinase Activators: From Benchside to Bedside
Friday, January 25 \| 9:20AM - 9:40AM Coffee Break Room: Foyer
Friday, January 25 \| 11:15AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Friday, January 25 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 1 of 6 * David E. Moller, Eli Lilly and Company, USA
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 2 of 6 * Jin-Long Chen, NGM Biopharmaceuticals, Inc., USA
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 3 of 6 Ranabir Sinha Roy, Merck & Co. Inc., USA DPP-4 Inhibitors and Next-Generation Insulin Secretagogues
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 4 of 6 Bryan Goodwin, Enanta Pharmaceuticals, USA Orphan Nuclear Receptors and Beyond in the Treatment of Metabolic Disease
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 5 of 6 Cord Dohrmann, Evotec AG, Germany Identifying Drug Targets Regulating Metabolism in Drosophila
Friday, January 25 \| 2:30PM - 4:30PM Drug Discovery Workshop Room: Colorado Ballroom Speaker 6 of 6 Brian Zambrowicz, Regeneron, USA Using Mouse Genetics to Understand Gene Function and Identify Targets for Drug Discovery
Friday, January 25 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Friday, January 25 \| 5:00PM - 7:00PM Novel Pathways in Diabetes and Metabolic Syndrome Room: Colorado Ballroom Speaker 1 of 5 * Barbara B. Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Friday, January 25 \| 5:00PM - 7:00PM Novel Pathways in Diabetes and Metabolic Syndrome Room: Colorado Ballroom Speaker 2 of 5 Philipp E. Scherer, University of Texas Southwestern Medical Center, USA Separating “Good” from “Bad” Adipose
Friday, January 25 \| 5:00PM - 7:00PM Novel Pathways in Diabetes and Metabolic Syndrome Room: Colorado Ballroom Speaker 3 of 5 Juleen R. Zierath, Karolinska Institutet, Sweden Down-Regulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance
Friday, January 25 \| 5:00PM - 7:00PM Novel Pathways in Diabetes and Metabolic Syndrome Room: Colorado Ballroom Speaker 4 of 5 Pere Puigserver, Dana-Farber Cancer Institute, Harvard Medical School, USA Sirtuins and Transcriptional Control in Hepatic Metabolism
Friday, January 25 \| 5:00PM - 7:00PM Novel Pathways in Diabetes and Metabolic Syndrome Room: Colorado Ballroom Speaker 5 of 5 Maziyar Saberi, NGM Biopharmaceuticals, USA Short Talk: Novel Liver-Specific TORC2 siRNA Corrects Hyperglycemia in Rodent Models of Type 2 Diabetes
Friday, January 25 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom
Friday, January 25 \| 7:30PM - 10:00PM Poster Session 3 Room: Breckenridge Ballroom
Saturday, January 26 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 1 of 8 * Philipp E. Scherer, University of Texas Southwestern Medical Center, USA
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 2 of 8 Barbara B. Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA RBP4 and Insulin Resistance
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 3 of 8 Deborah M. Muoio, Duke University Medical Center, USA Lipid-Induced Mitochondrial Stress and Insulin Resistance in Skeletal Muscle
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 4 of 8 Joyce J. Repa, University of Texas Southwestern Medical Center, USA The Oxysterol Nuclear Receptors and Glucose Homeostasis
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 5 of 8 Johan Auwerx, École Polytechnique Fédérale de Lausanne, Switzerland A Cofactor Network that Controls PGC-1alpha Activity and Energy Homeostasis
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 6 of 8 Alexander S. Banks, Harvard Medical School, USA Short Talk: Metabolic Mimicry of Calorie Restriction by SirT1 Gain-of-Function in Mice
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 7 of 8 Matthias Mann, Max Planck Institute of Biochemistry, Germany Short Talk: Mapping the Mitochondrial Proteome – Implications for Insulin Action and Diabetes
Saturday, January 26 \| 8:00AM - 11:30AM New Molecular Mechanisms of Insulin Resistance Room: Colorado Ballroom Speaker 8 of 8 Mark A. Febbraio, Monash Institute of Pharmaceutical Sciences, Australia Short Talk: Activating HSP72 Protects against Obesity-Induced Insulin Resistance
Saturday, January 26 \| 9:20AM - 9:40AM Coffee Break Room: Foyer
Saturday, January 26 \| 12:00PM - 1:30PM Meet the Professor Lunch: Perspectives of Science in Drug Di scovery and Careers in Industry Room: Colorado Ballroom Box Lunches available for purchase. Advance sign-up will be required. Speaker 1 of 3 * David E. Moller, Eli Lilly and Company, USA Introduction
Saturday, January 26 \| 12:00PM - 1:30PM Meet the Professor Lunch: Perspectives of Science in Drug Di scovery and Careers in Industry Room: Colorado Ballroom Box Lunches available for purchase. Advance sign-up will be required. Speaker 2 of 3 * Rebecca A. Taub, VIA Pharmaceuticals, Inc, USA
Saturday, January 26 \| 12:00PM - 1:30PM Meet the Professor Lunch: Perspectives of Science in Drug Di scovery and Careers in Industry Room: Colorado Ballroom Box Lunches available for purchase. Advance sign-up will be required. Speaker 3 of 3 * Thomas A. Gustafson, Johnson and Johnson, USA
Saturday, January 26 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Saturday, January 26 \| 5:00PM - 7:00PM Transcriptional Interface between Lipid and Glucose Metaboli sm Room: Colorado Ballroom Speaker 1 of 5 * Anna Krook, Karolinska Institutet, Sweden
Saturday, January 26 \| 5:00PM - 7:00PM Transcriptional Interface between Lipid and Glucose Metaboli sm Room: Colorado Ballroom Speaker 2 of 5 Marc R. Montminy, The Salk Institute for Biological Studies, USA The TORC Family of CREB Coactivators: Regulators of Energy Balance
Saturday, January 26 \| 5:00PM - 7:00PM Transcriptional Interface between Lipid and Glucose Metaboli sm Room: Colorado Ballroom Speaker 3 of 5 Markus Stoffel, ETH Zürich, Switzerland Cross-Talk between Insulin Signaling and FOXA2 in the Liver and Lateral Hypothalamus
Saturday, January 26 \| 5:00PM - 7:00PM Transcriptional Interface between Lipid and Glucose Metaboli sm Room: Colorado Ballroom Speaker 4 of 5 Bruce M. Spiegelman, Harvard Medical School, USA Transcriptional Control of Brown Fat Determination by PRDM16: A Co-Regulator of the PGC-1s and Nuclear Receptors
Saturday, January 26 \| 5:00PM - 7:00PM Transcriptional Interface between Lipid and Glucose Metaboli sm Room: Colorado Ballroom Speaker 5 of 5 Jiandie Lin, University of Michigan Medical School, USA Short Talk: Decoding the PGC-1 Transcriptional Network through Genome-Wide Coactivation Analyses
Saturday, January 26 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom
Saturday, January 26 \| 8:00PM - 11:00PM Entertainment Room: Breckenridge Ballroom
Saturday, January 26 \| 8:00PM - 11:00PM Cash Bar Room: Breckenridge Ballroom
Sunday, January 27 \| 10:25AM - 10:25AM Departure *Session Chair.